Nassif T, Prat F, Meduri B, Fritsch J, Choury A D, Dumont J L, Auroux J, Desaint B, Boboc B, Ponsot P, Cervoni J P
Department of Gastroenterology, CHU Bicêtre, 78 rue du General Leclerc, 94275 Le Kremlin-Bicêtre, France.
Endoscopy. 2003 Jun;35(6):483-9. doi: 10.1055/s-2003-39661.
Gastric outlet obstruction is a late event in the natural history of biliopancreatic tumours. Metallic self-expanding stents inserted under endoscopic and fluoroscopic guidance can be used for palliation. The aim of this study was to evaluate the feasibility, efficacy, and complications of endoscopic duodenal stenting in patients with malignant gastric outlet obstruction.
Between August 1998 and November 2001, 63 patients (31 women, 32 men; mean age 73 +/- 12) presenting with clinical symptoms of duodenal obstruction underwent endoscopic stenting with large metallic prostheses. Complications and clinical outcome were assessed both retrospectively and prospectively.
Of the patients, 58 needed one duodenal stent and two overlapping stents were required in five patients. Stenting was immediately successful in 60/63 patients (95%). At the time of the duodenal procedure, 25 previously inserted biliary stents were still patent; biliary stenting was attempted during the same procedure in 18 patients; and 20 patients had no biliary stricture. There was no procedure-related mortality. There were complications in 30 % of patients: 13 stent obstructions, 4 stent migrations and 2 duodenal perforations (treated surgically). For 44 patients (70%) there were no minor or major digestive problem during their remaining lifetime. An exclusively peroral diet was possible in 58 patients (92%), but was considered satisfactory (solid or soft) in 46/63 patients (73%). Of the patients, 53 (84 %) died between 1 and 64 weeks after the duodenal stenting (median survival 7 weeks).
Endoscopic stenting for the palliation of malignant gastric outlet obstruction is feasible and well-tolerated in most patients. Most dysfunctions can be managed endoscopically.
胃出口梗阻是胆胰肿瘤自然病程中的晚期事件。在内镜和荧光镜引导下插入的金属自膨式支架可用于缓解症状。本研究的目的是评估内镜下十二指肠支架置入术治疗恶性胃出口梗阻患者的可行性、疗效及并发症。
1998年8月至2001年11月,63例出现十二指肠梗阻临床症状的患者(31例女性,32例男性;平均年龄73±12岁)接受了大型金属假体的内镜下支架置入术。对并发症和临床结局进行了回顾性和前瞻性评估。
患者中,58例需要一个十二指肠支架,5例需要两个重叠支架。63例患者中有60例(95%)支架置入立即成功。在进行十二指肠手术时,25个先前置入的胆管支架仍通畅;18例患者在同一手术过程中尝试进行胆管支架置入;20例患者无胆管狭窄。无手术相关死亡。30%的患者出现并发症:13例支架阻塞、4例支架移位和2例十二指肠穿孔(手术治疗)。44例患者(70%)在余生中未出现轻微或严重的消化问题。58例患者(92%)可完全经口进食,但46/63例患者(73%)认为饮食满意(固体或软食)。53例患者(84%)在十二指肠支架置入后1至64周死亡(中位生存期7周)。
内镜下支架置入术缓解恶性胃出口梗阻对大多数患者是可行的且耐受性良好。大多数功能障碍可通过内镜处理。